NAD+ (Nicotinamide Adenine Dinucleotide) is a coenzyme essential for cellular energy production. It is commonly studied for its role in mitochondrial function, anti-aging research, and metabolic support.

NAD+ occupies a unique position in cellular biochemistry — it is simultaneously a redox carrier shuttling electrons through energy metabolism pathways and a signaling molecule whose intracellular concentration directly regulates the activity of NAD+-consuming enzymes including sirtuins, PARPs, and CD38. This dual role as both metabolic currency and enzymatic substrate makes it a research compound of unusual breadth, relevant across mitochondrial bioenergetics, epigenetic regulation, DNA damage response, and aging pathway research.

Research has characterized a progressive age-associated decline in intracellular NAD+ concentrations — approximately 50% between early and late adulthood in mammalian tissue models — with CD38 hydrolase upregulation in aged tissue preparations identified as a dominant driver of NAD+ consumption. This decline correlates with reduced sirtuin deacetylase activity, impaired mitochondrial function markers, and accumulating DNA damage signatures in cell-based aging models, positioning NAD+ availability as a regulatory nexus linking multiple aging-associated signaling pathways.

Kinetic characterization of SIRT1 has established that its deacetylase activity operates with a Km for NAD+ of approximately 170 μM under physiological conditions — meaning SIRT1 activity is sensitive to the physiological fluctuations in NAD+ concentration documented in aging cell preparations. This biochemical relationship between NAD+ availability and sirtuin activity is a primary focus of aging and longevity pathway research using NAD+ as a tool compound.

• CAS Number: 53-84-9
• Molecular Weight: 663.43 Da
• Purity: ≥99%
• Also Known As: NAD, Beta-NAD+, Nicotinamide Adenine Dinucleotide (oxidized form), Coenzyme I DPN (Diphosphopyridine Nucleotide, historical designation)
• Chemical Formula: C₂₁H₂₇N₇O₁₄P₂

In cell-based and biochemical models, NAD+ functions through two mechanistically distinct pathways. As a redox coenzyme, it accepts hydride equivalents during glycolysis, beta-oxidation, and the TCA cycle — cycling between its oxidized (NAD+) and reduced (NADH) forms to shuttle electrons to the mitochondrial electron transport chain, where their energy is captured through oxidative phosphorylation. This redox cycling activity is the central focus of mitochondrial bioenergetics and metabolic flux research using NAD+ as a substrate.

As an enzymatic co-substrate, NAD+ is cleaved at the nicotinamide-ribose bond by a family of NAD+-consuming enzymes. SIRT1 and other sirtuin deacetylases consume NAD+ during protein deacetylation reactions — releasing nicotinamide as a product inhibitor and O-acetyl-ADP-ribose as a byproduct. Structural characterization confirms NAD+ occupies a conserved Rossmann fold binding site during catalysis, and kinetic data establish that sirtuin activity is directly sensitive to intracellular NAD+ availability at physiologically relevant concentrations.

PARP enzymes consume NAD+ during ADP-ribosylation reactions at DNA damage sites — a DNA repair signaling pathway that competes with sirtuin activity for available NAD+ substrate in cell preparations under genotoxic stress conditions. CD38, a NAD+ hydrolase upregulated in aged tissue preparations, represents a third consumption pathway studied for its role in age-associated NAD+ depletion dynamics in cellular aging models.

• Sirtuin Activation and NAD+-Dependent Deacetylase Kinetics Studies
• Mitochondrial Bioenergetics and Oxidative Phosphorylation Research
• NAD+ Salvage and Biosynthesis Pathway Modeling
• PARP-Mediated DNA Repair and ADP-Ribosylation Studies
• CD38 Hydrolase Activity and Age-Associated NAD+ Depletion Research
• Cellular Aging and Redox Homeostasis Models
• Circadian Regulation and Metabolic Flux Studies